ORPHENADRINE 60 MG/2 ML VIAL

What it is

ORPHENADRINE 60 MG/2 ML VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as orphenadrine citrate.

FDA gives its dosage form as “injection” and “injection, solution” and its route as intramuscular; intravenous.

Its labelers, the companies named on the label, are Hikma Pharmaceuticals USA Inc. and Sagent Pharmaceuticals.

FDA’s Established Pharmacologic Class for it is Muscle Relaxant.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes); the FDA directory lists 2 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $5.73 – $7.07 for 1 mL, depending on the NDC ($5.73029 to $7.0744 per ML), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-07-22 and 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 4, carried forward from the previous file; 5, calculated based on package size.

The NADAC of 1 of these 3 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-07-22. The file is new; the price is not.

What NADAC measures · NADAC explanation codes · Carried-forward prices

All 3 NDCs

• 00641-6182-10 · not listed as a package in the FDA directory · $5.73029 per ML · eff. 2026-09-23 filed
• 00641-6182-25 · Hikma Pharmaceuticals USA Inc. · $7.0744 per ML · eff. 2026-07-22 filed carried forward
• 25021-0651-02 · Sagent Pharmaceuticals · $5.73029 per ML · eff. 2026-09-23 filed

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name orphenadrine citrate with ORPHENADRINE 60 MG/2 ML VIAL.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $6.55 for 1 mL, at an average of $6.55317 per ML in 2024 (2024-01-01 to 2024-12-31) for “Orphenadrine Citrate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 4,522 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 1 mL? Is it lower than what I would pay through my insurance?
• Which NDC (the 11-digit number on the package) is this? Pharmacies pay $5.73029 to $7.0744 per ML for this product, depending on the NDC.
• How much is in the package I am getting? This page uses 1 mL; your package may hold a different amount.
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.